Actively Recruiting
Essential Pro Study ( rEPIC04E-HK )
Led by Fundación EPIC · Updated on 2026-02-17
100
Participants Needed
1
Research Sites
76 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Single center, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Essential Pro to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Essential Pro.
CONDITIONS
Official Title
Essential Pro Study ( rEPIC04E-HK )
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient treated with Essential Pro according to routine hospital practice and following instructions for use
- Informed consent signed
You will not qualify if you...
- Not meet inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Princess Margaret Hospital
Lai Chi Kok, Hong Kong
Actively Recruiting
Research Team
F
FUNDACION EPIC
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here